Share

Mouse Study Finds FGF21 Directs Body’s Responses to Low-Protein Diet

Reducing the amount of protein in the diet produces an array of favorable health outcomes, including an extension of lifespan, and that these effects depend on Fibroblast Growth Factor 21 (FGF21), according to a study recently published in Nature Communications. It has long been known that reducing the amount you eat improves health and extends...
Share

New Study Makes Case for Culturing Embryos Up to Seven Days Post-Insemination for Selected Patients

Ending embryo culture at 144 hours (six days) post-insemination (h.p.i.) would involve 7.3 percent and 4.4 percent relative reductions in the number of patients obtaining euploid blastocysts and live birth(s) (LBs), respectively, according to a study published in Human Reproduction. The study results were announced recently by Fairtility, a company using artificial intelligence to enhance in...
Share

Tipping the Scales: Noninvasive Obesity Breakthroughs

June2022CoverEN As the worldwide mortality rate linked to obesity and its comorbidities surpasses four million annually, new approaches to combating this condition are sorely needed. Thankfully, recent research from Endocrine Society journals shows promise in some surprisingly novel and safe noninvasive weight loss methods. The obesity epidemic continues to pose serious health threats to populations worldwide....
Share

Middle Management: Evaluating New Insights to Obesity and Weight Control Options

June2022CoverEN As obesity continues to reach epidemic proportions, endocrine researchers are at the forefront of discovering new methods to help clinicians and patients alike to manage and even conquer obesity and its plethora of comorbidities. Here, we look at three recent studies that take these solutions from the bench to the bedside and even to the...
Share

New Cushing’s Syndrome Research Presented at ENDO 2022

The pharmacology data focus on the human body’s homeostatic response to potent HSD-1 inhibition by SPI-62. Results highlight that urinary free cortisol is distinct from intracellular cortisol that causes symptoms in patients with Cushing’s syndrome or autonomous cortisol secretion. Sparrow Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology...

As much as we know today about the endocrine system and the effects it has on the body, there remains so much that we do not know. Discoveries are made every day, and our understanding of the endocrine system is always growing and changing. Serving patients to the best of an endocrinologist’s abilities means being aware of all the latest developments in endocrine research. This includes the newest and most complete information concerning such endocrinology research topics as new treatments and new methods for disease prevention. Identifying symptoms and making the connections between those symptoms and endocrine disease can lead to greater understanding and ultimately better treatment for patients. More advanced prevention techniques can help patients stave off disease before it can impact their lives. Having the most current information can make a tremendous difference in the quality of life for your patients.

This section features some of the most current and forward-looking articles concerning the latest research in endocrinology. Written by and for endocrinologists, these articles are provided to keep you up to date with the most relevant developments in the field of endocrinology. You can access the information you need about new technology, new treatments and general information to help you serve your patients with better overall care. Our understanding of the endocrine system is always evolving. With Endocrine News, you can ensure that your knowledge of the field won’t be left behind. What’s more, your patients will always have access to the most advanced information out there.